Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring

Journal of the American College of Cardiology

Volumn 25, Issue 3, 1995, Pages 619-625

  Davies, Richard F ^a   Habibi, Habibullah ^a   Klinke, W Peter ^a   Dessain, Pierre ^a   Nadeau, Claude ^a   Phaneuf, Denis C ^a   Lepage, Serge ^a   Raman, Sankaranarayanan ^a   Herbert, Margaret ^a   Foris, Kathy ^a   Linden, Wolfgang ^a   Buttars, Jennifer A ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; PLACEBO;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BRADYCARDIA; BRONCHOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; EDEMA; FATIGUE; FEMALE; HEADACHE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; TREADMILL EXERCISE; VERTIGO; XEROSTOMIA;

AMLODIPINE; ATENOLOL; CROSS-OVER STUDIES; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; TIME FACTORS;

EID: 0028906622     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(94)00436-T     Document Type: Article

References (49)

1. Silent ischemia during daily life is an independent predictor of mortality in stable angina
2. Effects of asymptomatic ischemia on long-term prognosis in chronic stable coronary disease
3. Role of heart rate in pathophysiology of chronic stable angina
4. Prediction of the frequency and duration of ambulatory myocardial ischemia in patients with stable coronary artery disease by determination of the ischemic threshold from exercise testing: importance of the exercise protocol
5. Myocardial ischemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes
6. Mechanisms of nocturnal angina pectoris: importance of increased myocardial oxygen demand in patients with severe coronary artery disease
7. Circadian variation in ischemic threshold: a mechanism underlying the circadian variation in ischemic events
8. Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease
9. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina
10. Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia
11. Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia
12. Transient myocardial ischemia during daily life in rest and exertional angina pectoris and comparison of effectiveness of metoprolol versus nifedipine
13. Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery disease
14. Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris
15. Attenuation of the circadian patterns of myocardial ischemia with mifedipine GITS in patients with chronic stable angina
16. Comparative effects of calcium entry-blocking drugs, beta-blocking drugs and their combination in patients with chronic stable angina
17. Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination
18. Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study
19. Effects of nifedipine and diltiazem on myocardial ischemia in patients with severe stable angina pectoris treated with nitrates and beta-blockers
20. Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris
21. The pharmacokinetic profile of amlodipine
22. Pharmacologic profile of amlodipine
23. Coronary collaterals reduce the duration of exercise-induced ischemia by allowing a faster recovery
24. Amlodipine in patients with stable angina pectoris treated with nitrates and beta-blockers
25. The role of calcium antagonists in the treatment of myocardial ischemia
26. Effects of calcium entry blockade on myocardial blood flow
27. Nisoldipine in the therapy of stable exercise angina: evaluation of its efficacy in ergometric tests compared with propranolol
28. Effects of nicardipine on exercise and pacing-induced myocardial ischemia in angina pectoris
29. Comparison of nicardipine and propranolol for chronic stable angina pectoris
30. Medical treatment of patients with severe exertional and rest angina: double blind comparison of beta blocker, calcium antagonist, and nitrate
31. Felodipine in chronic stable angina: a randomized, double-blind, placebo-controlled, crossover study
32. International beta-blocker review in acute and postmyocardial infarction
33. Secondary prevention trials after acute myocardial infarction
34. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease
35. Effect of intravenous propranolol on coronary vasomotion at rest and during dynamic exercise in patients with coronary artery disease
36. Beta blockers enhance coronary vasoreactive response to acetylcholine in patients with chronic stable angina
37. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis
38. Pathophysiology of silent myocardial ischemia during daily life
39. Relations between heart rate, ischemia, and drug therapy during daily life in patients with coronary artery disease
40. Angina and Silent Ischemia Study Group (ASIS): Subsets of ambulatory myocardial ischemia based on heart rate activity: circadian distribution and response to anti-ischemic medication
41. Myocardial ischemia and mental stress in daily activities
42. Myocardial ischemia due to mental stress
43. Mental stress and the induction of myocardial ischemia in patients with coronary artery disease
44. Asymptomatic myocardial ischemia following cold provocation
45. Direct effects of smoking on the heart: silent ischemic disturbances of coronary flow
46. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome
47. Silent ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients
48. Silent ischemia as a marker for early unfavourable outcomes in patients with unstable angina
49. Asympatomatic Cardiac Ischemia Pilot Study (ACIP)